Advertisement
Canada markets closed
  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CAD/USD

    0.7249
    -0.0014 (-0.20%)
     
  • CRUDE OIL

    86.06
    +3.33 (+4.03%)
     
  • Bitcoin CAD

    83,551.35
    -1,483.76 (-1.74%)
     
  • CMC Crypto 200

    1,242.42
    +356.88 (+37.39%)
     
  • GOLD FUTURES

    2,415.00
    +17.00 (+0.71%)
     
  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     
  • 10-Yr Bond

    4.6470
    +0.0620 (+1.35%)
     
  • NASDAQ futures

    17,257.50
    -289.75 (-1.65%)
     
  • VOLATILITY

    18.00
    -0.21 (-1.15%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • NIKKEI 225

    36,818.81
    -1,260.89 (-3.31%)
     
  • CAD/EUR

    0.6825
    +0.0004 (+0.06%)
     

Stocks - CA, Zogenix Soar in Pre-market, Broadcom, L Brands Sink, Walmart Gains

Stocks in focus in pre-market trade on Thursday
Stocks in focus in pre-market trade on Thursday

Investing.com - Stocks in focus in pre-market trade Thursday:

• CA (CA) stock skyrocketed 18.3% by 8:23 AM ET (12:23 GMT) after Broadcom (AVGO) confirmed that it will acquire the firm for $44.50 per share or $18.9 billion. Broadcom stock sank 9.7%.

• Walmart (WMT) stock gained 0.5% amid a Nikkei report that the firm is looking for buyers for its Japanese supermarket chain Seiyu.

• Delta Air Lines (DAL) stock rose 1.7% as it reported quarterly adjusted earnings per diluted share of $1.77, beating estimates for $1.74. Shares remained higher despite the fact that the airline cut its full-year earnings outlook to a range of $5.35 to $5.70 per share due to an expected $2 billion higher fuel bill for 2018.

ADVERTISEMENT

• L Brands (LB) stock tumbled 7.3% as the firm reported a 3% rise in comparable store sales for the five weeks ending on July 7, slower than the 5% gain seen a month earlier.

• Zogenix Inc (ZGNX) stock soared 21% as it announced positive results from a late stage trial of its drug used in the treatment of epilepsy.

Related Articles

Stock futures rise as big deals, earnings hope dull tariff fears

Rising fares push Delta past profit estimates

Goldman ups Twitter estimates; shares gain 1.9% premarket